Department of Gynaecologic Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom; Charite Comprehensive Cancer Center, Berlin, Germany.
Department of Gynaecologic Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Gynecol Oncol. 2018 Dec;151(3):466-470. doi: 10.1016/j.ygyno.2018.09.028. Epub 2018 Sep 29.
Evaluate postoperative hepatic-function in patients with advanced ovarian cancer (OC) who underwent extensive right upper-quadrant (RUQ) cytoreduction in primary, relapsed or interval settings.
We retrospectively reviewed all patients with OC who underwent liver resection, mobilization and/or diaphragmatic-stripping between 01/2013 and 12/2016. Postoperative liver enzyme function (LFTs), assessed by alanine transaminase (ALT), alkaline phosphatase (ALP) and bilirubin (Bil), was correlated with postoperative complications.
132 patients were identified. 81 patients (61%) underwent upfront, 25(19%) interval and 26(20%) secondary cytoreduction. The surgical procedures were right diaphragmatic peritoneal stripping (81/132;61%), full-thickness resection (42/132;32%), liver-capsule resection (85/132;64%), porta-hepatis tumor resection (11/132;8%) and partial hepatectomy (5/132;4%). 74%(98/132) of patients increased their LFTs postoperatively with a peak at 24-hours. Highest ALT median was 1.7-fold of upper normal limit (UNL), with the highest ALT value rising up to 28-fold UNL on the 1st postoperative day (PoD)(range 6-1792 IU/L). Median value of highest ALP was within normal, with the highest ALP value rising up to 4-fold UNL on PoD 5(range 22-512 IU/L). Median value of highest Bilirubin level was also within normal, with highest Bilirubin level rising up to 6-fold UNL on PoD 5(range: 2-120 μmol/L). Mean LFT-normalization time was 7 days (range: 3-14 days). No significant morbidity was directly linked to LFT deterioration, apart from one case (0.8%) of fatal fulminant hepatic-failure.
RUQ-cytoreduction is almost always associated with a transient LFT-increase, with no significant clinical implications and spontaneous normalization within the first postoperative week. Due to the existing risk of fulminant liver failure, albeit rare and difficult to predict, postoperatively elevated LFTs should be monitored, until normalization. Large prospective studies are required to assess the predictive value of LFTs and other risk factors for postoperative hepatic failure in patients with OC undergoing extensive RUQ-cytoreduction.
评估在原发性、复发性或间隔期行广泛右上腹(RUQ)减瘤术的晚期卵巢癌(OC)患者的术后肝功能。
我们回顾性分析了 2013 年 1 月至 2016 年 12 月期间所有接受过肝切除术、肝游离和/或膈肌剥离的 OC 患者。通过丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)和胆红素(Bil)评估术后肝功能(LFTs),并与术后并发症相关联。
共确定了 132 例患者。81 例(61%)行初次手术,25 例(19%)行间隔期手术,26 例(20%)行二次手术。手术方式为右侧膈肌腹膜剥离(81/132;61%)、全层切除术(42/132;32%)、肝包膜切除术(85/132;64%)、肝门肿瘤切除术(11/132;8%)和部分肝切除术(5/132;4%)。74%(98/132)的患者术后 LFT 升高,术后 24 小时达高峰。ALT 中位数最高为正常值上限(UNL)的 1.7 倍,术后第 1 天(PoD)最高 ALT 值升高至 28 倍 UNL(范围 6-1792IU/L)。ALP 中位数最高值在正常范围内,术后第 5 天(PoD5)最高 ALP 值升高至 4 倍 UNL(范围 22-512IU/L)。胆红素最高水平的中位数也在正常范围内,术后第 5 天(PoD5)最高胆红素水平升高至 6 倍 UNL(范围:2-120μmol/L)。平均 LFT 正常化时间为 7 天(范围:3-14 天)。除 1 例(0.8%)致命性暴发性肝衰竭外,无明显与 LFT 恶化直接相关的并发症。
RUQ 减瘤术几乎总是与短暂的 LFT 升高相关,无明显临床意义,术后第 1 周内自发恢复正常。由于存在暴发性肝衰竭的风险,尽管罕见且难以预测,但术后应监测 LFT 升高,直至正常化。需要进行大型前瞻性研究,以评估在接受广泛 RUQ 减瘤术的 OC 患者中,LFT 及其他肝衰竭危险因素对术后肝功能的预测价值。